R. Doty
Neurology · 2010–2020
A researcher in the Science corpus: 3 papers; trusts 3 researchers and is trusted by 0 researchers here, as inferred from the citation graph.
Subfields
- Neurology — 16 citations into it
Whom R. Doty trusts overall
Their strongest outbound trust, strongest first, inferred from their citations.
Papers from R. Doty's perspective
Ordered by how strongly the researchers R. Doty trusts endorse each paper. Same corpus, a different order for every researcher.
- ACE-2 expression in the small airway epithelia of smokers and COPD patients: implications for COVID-19 (European Respiratory Journal)
- SARS-CoV-2 Viral Load in Upper Respiratory Specimens of Infected Patients (New England Journal of Medicine)
- Where Does Parkinson Disease Pathology Begin in the Brain? (Journal of Neuropathology and Experimental Neurology)
- Staging of brain pathology related to sporadic Parkinson's disease. (Neurobiology of Aging)
- Pathoanatomy of Parkinson’s disease (Journal of Neurology)
- Alpha-synuclein and neurodegenerative diseases (Nature Reviews Neuroscience)
- Aggresomes, inclusion bodies and protein aggregation. (Trends in Cell Biology)
- Age-related myelin breakdown: a developmental model of cognitive decline and Alzheimer's disease. (Neurobiology of Aging)
- Proteasomal function is impaired in substantia nigra in Parkinson's disease. (Neuroscience Letters)
- Idiopathic hyposmia as a preclinical sign of Parkinson's disease (Annals of Neurology)
Their papers
- Smell dysfunction: a biomarker for COVID‐19 (2020) — 757 citations
- Olfactory dysfunction in Parkinson disease (2012) — 703 citations
- The Great Pheromone Myth (2010) — 84 citations